Company Filing History:
1 out of 3,540 
1 out of 870 
1 out of 5,094 
Years Active: 2005-2008
Title: Pierre Buffet: Innovator in Malaria Research
Introduction
Pierre Buffet is a notable inventor based in Paris, France. He has made significant contributions to the field of malaria research, particularly in understanding the mechanisms of Plasmodium falciparum infections. With a total of 2 patents, his work has implications for diagnostics and therapeutics in combating malaria.
Latest Patents
Pierre Buffet's latest patents include groundbreaking inventions related to the proteins involved in cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes. His first patent focuses on antibodies that bind to these proteins, along with methods for detecting infection, determining the stage of infection, and developing vaccines for protection against malaria. The second patent identifies the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A. This discovery has led to the development of novel biological tools, prophylactics, therapeutics, diagnostics, and methods of use.
Career Highlights
Throughout his career, Pierre Buffet has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Institut Pasteur. His research has been pivotal in advancing our understanding of malaria and its treatment.
Collaborations
Pierre has collaborated with esteemed colleagues, including Artur Scherf and Bruno Pouvelle, to further enhance the impact of his research in the field of infectious diseases.
Conclusion
Pierre Buffet's innovative work in malaria research has led to significant advancements in understanding and combating this deadly disease. His contributions through patents and collaborations continue to influence the field positively.